Screener
Eton Pharmaceuticals, Inc. ETON Pre-Tax Income
Pre-Tax Income at other companies
Other financials
Where this comes from
Reported directly by Eton Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest.
The source filing: Eton Pharmaceuticals, Inc.’s 10-Q, filed May 14, 2026.
- Filed
- May 14, 2026, 4:17 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001437749-26-017064
| Line item | For the three months ended / March 31, 2026 | For the three months ended / March 31, 2025 |
|---|---|---|
| Income (loss) from operations | 2,414 | (470) |
| Other expense: | ||
| Interest and other expense, net | (840) | (1,028) |
| Income (loss) before income tax expense | 1,574 | (1,498) |
| Income tax expense | 20 | 74 |
| Net income (loss) | $1,554 | $(1,572) |
| Net income (loss) per share, basic | $0.06 | $(0.06) |
| Weighted average number of common shares outstanding, basic | 27,285 | 26,886 |
Document
FAQ
- What is Eton Pharmaceuticals, Inc.'s pre-tax income?
- Eton Pharmaceuticals, Inc. (ETON) reported pre-tax income of $1.57M in Q1 2026.
- How has Eton Pharmaceuticals, Inc.'s pre-tax income changed year-over-year?
- Eton Pharmaceuticals, Inc.'s pre-tax income increased by 205.1% year-over-year, from -$1.5M to $1.57M.
- What does pre-tax income mean?
- Total income from all sources — operating income plus non-operating items like interest income, investment gains, and other income — before the provision for income taxes.
Ask your AI about Eton Pharmaceuticals, Inc.'s pre-tax income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude